Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-03-02 @ 4:00 PM
Study NCT ID:
NCT00548002
Status:
COMPLETED
Last Update Posted:
2007-10-23
First Post:
2007-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
Sponsor:
University of Helsinki
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FINLEVO
Brief Summary:
To study whether fluoroquinolone (trovafloxacin or levofloxacin), added to standard treatment, could reduce the high mortality and complication rates in Staphylococcus aureus bacteremia.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: